MAPK8 and fatty liver disease: p38 is activated as well, via TRAF [103] or PKC [179], and together with JNK and PKC can contribute to both insulin resistance and hepatic steatosis [103,173,180,181], although there is some controversy about the p38 effect on hepatic lipid metabolism [182].